Left ventricular noncompaction in patients with coronary artery disease: Preliminary analysis of echocardiographic

Xiangming Zhu1, Yang Ya2, Guobing Hu1

  • 1Department of Ultrasound, The First Affiliated Hospital of Wannan Medical College, Wuhu, China.

Insights

Echocardiography revealed left ventricular noncompaction (LVNC) and coronary artery disease in eight patients. While echocardiography shows abnormalities, distinguishing causes remains challenging.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Left ventricular noncompaction (LVNC) is a rare congenital heart defect.
  • Coronary artery disease (CAD) affects millions worldwide.
  • Concurrent LVNC and CAD present diagnostic challenges.

Purpose of the Study:

  • To analyze echocardiographic findings in patients with both LVNC and CAD.
  • To assess the utility of echocardiography in diagnosing these co-occurring conditions.

Main Methods:

  • Retrospective analysis of echocardiographic data from eight patients.
  • Patients diagnosed with LVNC and CAD between January 2012 and May 2017.
  • Review of coronary artery disease types including atherosclerosis, fistula, and myocardial bridge.

Main Results:

  • All eight patients exhibited regional wall motion abnormalities on echocardiography.
  • Six patients had coronary arterial atherosclerosis.
  • One patient had a coronary pulmonary fistula, and another had a coronary myocardial bridge.

Conclusions:

  • Echocardiography provides valuable insights into LVNC in the presence of CAD.
  • Differentiating the etiology of wall motion abnormalities between LVNC and CAD requires further investigation.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
492
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
283
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
391
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
387